 This study will involve the used of a synthetic biodegradable Poly Lactide-co-Glycolic Acid PLGA biodegradable, synthetic carrier membrane PLGA membrane as a substitute for using donor human amniotic membrane hAM for the treatment of limbal stem cell deficiency LSCD by combining this with freshly excised limbal tissue in theatre as a one stage procedure. 